Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 17 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 541 (84%) | |
Discontinuation Reports |
233 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 233 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
80 (9%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-CELECOXIB | 100MG | CAPSULE | Resolved | 2017-03-10 | 2017-03-14 | 137 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Resolved | 2017-03-10 | 2017-03-14 | 226 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2017-03-10 | 2017-03-15 | 191 |
| CLARUS | 10MG | CAPSULE | Resolved | 2017-03-10 | 2017-03-22 | 143 |
| CLARUS | 40MG | CAPSULE | Resolved | 2017-03-10 | 2017-03-22 | 148 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-03-24 | 128 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-03-24 | 131 |
| MYLAN-RISPERIDONE | 4.0MG | TABLET | Avoided shortage | 2017-03-17 | 2017-03-29 | 3368 |
| MYLAN-NITRO PATCH 0.8 | 82.9MG | PATCH (EXTENDED RELEASE) | Avoided shortage | 2017-03-23 | 2017-03-29 | 4080 |
| MYLAN-INDAPAMIDE | 2.5mg | Tablet | Resolved | 2017-03-10 | 2017-03-31 | 194 |
| MYLAN-INDAPAMIDE | 2.5MG | TABLET | Resolved | 2017-03-23 | 2017-04-04 | 4073 |
| MYLAN-BUPRENORPHINE/NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-03-22 | 2017-04-12 | 3922 |
| MYLAN-ENTACAPONE | 200MG | TABLET | Avoided shortage | 2017-04-07 | 2017-04-13 | 5954 |
| MYLAN-MINOCYCLINE | 50MG | CAPSULE | Avoided shortage | 2017-04-07 | 2017-04-13 | 5934 |
| MYLAN-CELECOXIB | 100MG | CAPSULE | Resolved | 2017-03-31 | 2017-04-21 | 5009 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-04-17 | 2017-05-02 | 7131 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Avoided shortage | 2017-03-23 | 2017-05-03 | 4083 |
| MYLAN-AMIODARONE | 200MG | TABLET | Avoided shortage | 2017-03-23 | 2017-05-04 | 4090 |
| MYLAN-AMIODARONE | 200MG | TABLET | Avoided shortage | 2017-03-31 | 2017-05-04 | 5046 |
| MYLAN-MONTELUKAST | 10MG | TABLET | Avoided shortage | 2017-04-07 | 2017-05-05 | 5946 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| MYLAN-TOLTERODINE ER | 2MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155037 |
| MYLAN-TOLTERODINE ER | 4MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2022-02-15 | 2022-02-15 | 155040 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |